Extracellular peptide ligand binding sites, which bind the N-termini of angiotensin II (AngII) and bradykinin (BK) peptides, are located on the N-terminal and extracellular loop 3 regions of the AT(1)R and BKRB1 or BKRB2 G-protein-coupled receptors (GPCRs). Here we synthesized peptides P15 and P13 corresponding to these receptor fragments and showed that only constructs in which these peptides were linked by S-S bond, and cyclized by closing the gap between them, could bind agonists. the formation of construct-agonist complexes was revealed by electron paramagnetic resonance spectra and fluorescence measurements of spin labeled biologically active analogs of AngII and BK (Toac(1)-AngII and Toac(0)-BK), where Toac is the amino acid-type para...
Peptide agonists and antagonists of both bradykinin (BK) B1 and B2 receptors (B1R, B2R) are known to...
Peptide agonists and antagonists of both bradykinin (BK) B1 and B2 receptors (B1R, B2R) are known to...
Mutating the side-chains of amino acids in a peptide ligand, with unnatural amino acids, aiming to m...
Angiotensin II (Ang II) and its transmembrane AT(1) receptor were selected in order to test an innov...
Angiotensin II (Ang II) and its transmembrane AT(1) receptor were selected in order to test an innov...
Angiotensin II (Ang II) and its transmembrane AT(1) receptor were selected in order to test an innov...
This study characterized pharmacologically the functional responses to agonists angiotensin II (AngI...
AbstractMutant forms of kinin B1 receptor (B1R) and analogs of the full agonist des-Arg9-bradykinin ...
The G protein-coupled receptors (GPCRs) are important targets in drug discovery. In several cases, t...
N-Terminally and internally labeled analogues of the hormones angiotensin (All, DRVYIHPF) and bradyk...
Important information on the bioactive conformation of biologically active peptides may be obtained ...
N-Terminally and internally labeled analogues of the hormones angiotensin (AII, DRVYIHPF) and bradyk...
In the past decade a great deal of structural information for class A-GPCRs (G protein-coupled recep...
This study addresses the issue of how to convert peptides into drug-like non-peptides while retainin...
In the past decade a great deal of structural information for class A-GPCRs (G protein-coupled recep...
Peptide agonists and antagonists of both bradykinin (BK) B1 and B2 receptors (B1R, B2R) are known to...
Peptide agonists and antagonists of both bradykinin (BK) B1 and B2 receptors (B1R, B2R) are known to...
Mutating the side-chains of amino acids in a peptide ligand, with unnatural amino acids, aiming to m...
Angiotensin II (Ang II) and its transmembrane AT(1) receptor were selected in order to test an innov...
Angiotensin II (Ang II) and its transmembrane AT(1) receptor were selected in order to test an innov...
Angiotensin II (Ang II) and its transmembrane AT(1) receptor were selected in order to test an innov...
This study characterized pharmacologically the functional responses to agonists angiotensin II (AngI...
AbstractMutant forms of kinin B1 receptor (B1R) and analogs of the full agonist des-Arg9-bradykinin ...
The G protein-coupled receptors (GPCRs) are important targets in drug discovery. In several cases, t...
N-Terminally and internally labeled analogues of the hormones angiotensin (All, DRVYIHPF) and bradyk...
Important information on the bioactive conformation of biologically active peptides may be obtained ...
N-Terminally and internally labeled analogues of the hormones angiotensin (AII, DRVYIHPF) and bradyk...
In the past decade a great deal of structural information for class A-GPCRs (G protein-coupled recep...
This study addresses the issue of how to convert peptides into drug-like non-peptides while retainin...
In the past decade a great deal of structural information for class A-GPCRs (G protein-coupled recep...
Peptide agonists and antagonists of both bradykinin (BK) B1 and B2 receptors (B1R, B2R) are known to...
Peptide agonists and antagonists of both bradykinin (BK) B1 and B2 receptors (B1R, B2R) are known to...
Mutating the side-chains of amino acids in a peptide ligand, with unnatural amino acids, aiming to m...